Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Reversion of metabolic dysfunction-associated steatohepatitis by skeletal muscle-directed FGF21 gene therapy

  • Jimenez, Veronica|||0000-0001-9145-9877
  • Sacristan, Victor|||0000-0003-0356-0356
  • Jambrina Pallarés, Claudia|||0000-0002-9093-5568
  • Jaén Sitges, Maria Luisa|||0000-0002-9188-0810
  • Casaña Lorente, Estefania|||0000-0002-1353-5018
  • Muñoz-Martínez, S.|||0000-0003-0663-0575
  • Marcó, Sara|||0000-0003-3502-5198
  • Molas Laplana, Maria|||0000-0002-3215-515X
  • Garcia, Miquel|||0000-0002-1602-4993
  • Grass Costa, Ignasi|||0000-0002-6917-3271
  • León, Xavier|||0000-0002-8393-2721
  • Elias Puigdomenech, Ivet|||0000-0002-1304-9597
  • Ribera Sánchez, Albert|||0000-0002-7120-4276
  • Elias Bosch, Gemma|||0000-0003-1985-7955
  • Sánchez Clares, Víctor|||0000-0001-8631-9239
  • Vilà, Laia|||0000-0002-1211-5804
  • Casellas Comallonga, Alba|||0000-0003-0203-4733
  • Ferre, Tura|||0000-0001-9713-0829
  • Rodó Morera, Jordi|||0000-0001-8533-2597
  • Carretero i Romay, Ana|||0000-0001-9377-4926
  • Pumarola i Batlle, Martí|||0000-0002-0935-7941
  • Navarro Beltrán, Marc|||0000-0002-9678-6129
  • Andaluz Martínez, Anna|||0000-0001-8097-8110
  • Moll, Xavier|||0000-0002-2992-9361
  • Añor Torres, Sònia|||0000-0002-1099-7698
  • Franckhauser, Sylvie|||0000-0001-5255-1224
  • Vergara, Mercedes|||0000-0002-6971-8657
  • Caixàs i Pedragós, Assumpta|||0000-0001-8472-9189
  • Bosch i Tubert, Fàtima|||0000-0002-7705-5515
The highly prevalent metabolic dysfunction-associated steatohepatitis (MASH) is associated with liver steatosis, inflammation, and hepatocyte injury, which can lead to fibrosis and may progress to hepatocellular carcinoma and death. New treatment modalities such as gene therapy may be transformative for MASH patients. Here, we describe that one-time intramuscular administration of adeno-associated viral vectors of serotype 1 (AAV1) encoding native fibroblast growth factor 21 (FGF21), a key metabolic regulator, resulted in sustained increased circulating levels of the factor, which mediated long-term (.